{"id":49136,"date":"2022-10-04T16:01:58","date_gmt":"2022-10-04T14:01:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/"},"modified":"2022-10-04T16:01:58","modified_gmt":"2022-10-04T14:01:58","slug":"adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/","title":{"rendered":"Adam Seidner MD MPH, Chief Medical Officer at The Hartford and Medical Policy Expert, Joins Harvard MedTech\u2019s Medical Advisory Board"},"content":{"rendered":"
\n

LAS VEGAS–(BUSINESS WIRE)–Adam Seidner, M.D., a thought leader in medical policy development with a particular focus on Workers\u2019 Compensation and Disability Management, has been appointed to the Medical Advisory Board of Harvard MedTech<\/a>.\n<\/p>\n

<\/a><\/p>\n

\n\u201cDr. Seidner\u2019s expertise in public health issues, coupled with his experience in employee health initiatives, make him a valuable addition to Harvard MedTech\u2019s Medical Advisory Board,\u201d said Gerry Stanley, M.D., Chief Medical Officer, Harvard MedTech. \u201cDr. Seidner\u2019s work at The Hartford around employee safety and mental health have set new standards in the industry. We look forward to his innovative approach as a member of our Medical Advisory Board.\u201d\n<\/p>\n

\nDr. Seidner has served as Chief Medical Officer at The Hartford since 2017. Previously, Dr. Seidner was global medical director for Travelers Insurance, where he was responsible for medical policy development, quality assurance and improvement, and worksite health promotion. Prior to joining Travelers, he was the owner and chief health advisor at Medical Meetinghouse. Dr. Seidner earned a Doctor of Medicine degree from SUNY Health Science Center, a Master’s degree in Public Health from the University of Connecticut and an A.B. in Anthropology from Hamilton College. He is board certified by the American Board of Family Practice and the Board of Preventative Medicine: Occupational and Environmental Medicine. Additionally, Dr. Seidner is the 2021 recipient of the Comp Laud award for his invaluable service and contributions to the Workers Compensation industry.\n<\/p>\n

\nThe purpose of the Harvard MedTech Medical Advisory Board is to foster industry-wide innovation around Vx\u00ae Therapy in the treatment of workplace trauma. Vx Therapy is a disruptive approach that uses virtual reality, behavioral coaching and artificial intelligence to alter the brain\u2019s experience of pain, without drugs or unnecessary surgery. Each member\u2019s specific expertise lends a particular lens on pain management which has been determined to have significant strategic importance, as Harvard MedTech works to make the world a better place by alleviating human suffering.\n<\/p>\n

\n\u201cJoining with Dr. Stanley and other members of the Medical Advisory Board to develop new applications of Harvard MedTech\u2019s innovative technology is an exciting opportunity to advance the science of pain management,\u201d said Dr. Seidner of his appointment. \u201cI am looking forward to collaborating with other Board members for the benefit of injured workers nationwide.\u201d\n<\/p>\n

\nAbout Harvard MedTech<\/span><\/b>\n<\/p>\n

\nHarvard MedTech is a breakthrough digital health company that is tapping the new science of how the brain works, combining specially designed virtual reality experiences, psychosocial support, digital engagement, and proprietary AI algorithms to retrain neural pathways and alleviate the effects of trauma, including pain, PTSD, anxiety, depression and sleep disorders. The company\u2019s Vx\u00ae Therapy model is the first to comprehensively integrate this unique combination of digital technologies with behavioral health interventions, in a virtual application that moves the points of care to the patient\u2019s home. This virtual engagement drives high compliance, patient satisfaction and optimal outcomes. It also allows the solution to be affordable and scalable at a population health level. This non-invasive and non-pharmacological approach also provides data that is trackable for a clear assessment of its value to patients and health care providers. Visit www.harvardmedtech.com<\/a> for more information.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nJoy Scott
\n
joy@scottpublicrelations.com<\/a>
(818) 610-0270\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LAS VEGAS–(BUSINESS WIRE)–Adam Seidner, M.D., a thought leader in medical policy development with a particular focus on Workers\u2019 Compensation and Disability Management, has been appointed to the Medical Advisory Board of Harvard MedTech. \u201cDr. Seidner\u2019s expertise in public health issues, coupled with his experience in employee health initiatives, make him a valuable addition to Harvard … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49136","6":"format-standard","7":"category-industry"},"yoast_head":"\nAdam Seidner MD MPH, Chief Medical Officer at The Hartford and Medical Policy Expert, Joins Harvard MedTech\u2019s Medical Advisory Board - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adam Seidner MD MPH, Chief Medical Officer at The Hartford and Medical Policy Expert, Joins Harvard MedTech\u2019s Medical Advisory Board - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LAS VEGAS–(BUSINESS WIRE)–Adam Seidner, M.D., a thought leader in medical policy development with a particular focus on Workers\u2019 Compensation and Disability Management, has been appointed to the Medical Advisory Board of Harvard MedTech. \u201cDr. Seidner\u2019s expertise in public health issues, coupled with his experience in employee health initiatives, make him a valuable addition to Harvard ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-04T14:01:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221004005341\/en\/1582841\/21\/2021HarvardMedTechLogo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Adam Seidner MD MPH, Chief Medical Officer at The Hartford and Medical Policy Expert, Joins Harvard MedTech\u2019s Medical Advisory Board\",\"datePublished\":\"2022-10-04T14:01:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\\\/\"},\"wordCount\":558,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005341\\\/en\\\/1582841\\\/21\\\/2021HarvardMedTechLogo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\\\/\",\"name\":\"Adam Seidner MD MPH, Chief Medical Officer at The Hartford and Medical Policy Expert, Joins Harvard MedTech\u2019s Medical Advisory Board - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005341\\\/en\\\/1582841\\\/21\\\/2021HarvardMedTechLogo.jpg\",\"datePublished\":\"2022-10-04T14:01:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005341\\\/en\\\/1582841\\\/21\\\/2021HarvardMedTechLogo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221004005341\\\/en\\\/1582841\\\/21\\\/2021HarvardMedTechLogo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Adam Seidner MD MPH, Chief Medical Officer at The Hartford and Medical Policy Expert, Joins Harvard MedTech\u2019s Medical Advisory Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adam Seidner MD MPH, Chief Medical Officer at The Hartford and Medical Policy Expert, Joins Harvard MedTech\u2019s Medical Advisory Board - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/","og_locale":"en_US","og_type":"article","og_title":"Adam Seidner MD MPH, Chief Medical Officer at The Hartford and Medical Policy Expert, Joins Harvard MedTech\u2019s Medical Advisory Board - Pharma Trend","og_description":"LAS VEGAS–(BUSINESS WIRE)–Adam Seidner, M.D., a thought leader in medical policy development with a particular focus on Workers\u2019 Compensation and Disability Management, has been appointed to the Medical Advisory Board of Harvard MedTech. \u201cDr. Seidner\u2019s expertise in public health issues, coupled with his experience in employee health initiatives, make him a valuable addition to Harvard ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-04T14:01:58+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221004005341\/en\/1582841\/21\/2021HarvardMedTechLogo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Adam Seidner MD MPH, Chief Medical Officer at The Hartford and Medical Policy Expert, Joins Harvard MedTech\u2019s Medical Advisory Board","datePublished":"2022-10-04T14:01:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/"},"wordCount":558,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221004005341\/en\/1582841\/21\/2021HarvardMedTechLogo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/","url":"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/","name":"Adam Seidner MD MPH, Chief Medical Officer at The Hartford and Medical Policy Expert, Joins Harvard MedTech\u2019s Medical Advisory Board - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221004005341\/en\/1582841\/21\/2021HarvardMedTechLogo.jpg","datePublished":"2022-10-04T14:01:58+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221004005341\/en\/1582841\/21\/2021HarvardMedTechLogo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221004005341\/en\/1582841\/21\/2021HarvardMedTechLogo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/adam-seidner-md-mph-chief-medical-officer-at-the-hartford-and-medical-policy-expert-joins-harvard-medtechs-medical-advisory-board\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Adam Seidner MD MPH, Chief Medical Officer at The Hartford and Medical Policy Expert, Joins Harvard MedTech\u2019s Medical Advisory Board"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49136","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49136"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49136\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49136"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49136"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49136"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}